Compound Detail
CHEMBL5562993
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)N(C)C(=O)C[C@@H](C(=O)N(C)C)N(C)C(=O)[C@H](C2CCCC2)N(C)C(=O)C2(CCCC2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCc2ccc(C(F)(F)F)c(Cl)c2)NC(=O)CN(C)C(=O)[C@H](CC2CCCCC2)N(C)C(=O)[C@@H]2CCN2C(=O)[C@H](C)N(C)C1=O
Basic Information
| ChEMBL ID | CHEMBL5562993 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | CKXOWGKJLADMGE-UJLGBSNOSA-N |
2
Targets
2
Activities
2
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
1414.2
MW (Da)
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 8.26
Kd 1 meas. best 9.8
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| GTPase KRas CHEMBL2189121 | Kd | 9.8 | 9.8 | 0.2 | 1 |
| ASPC1 CHEMBL612588 | IC50 | 8.26 | 8.26 | 5.5 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| GTPase KRas | Kd | = | 0.16 | nM | 9.8 | Binding affinity to biotinylated KRAS G12D mutant (unknown origin) incubated for... | 38981216 |
| ASPC1 | IC50 | = | 5.5 | nM | 8.26 | Cytotoxicity against human AsPC1 cells assessed as reduction in cell viability i... | 38981216 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 38981216 | 10.1016/j.bmc.2024.117830 | Unchecked | 1 |
| 38981216 | 10.1016/j.bmc.2024.117830 | GTPase KRas | 1 |
| 38981216 | 10.1016/j.bmc.2024.117830 | ASPC1 | 1 |
| 38981216 | 10.1016/j.bmc.2024.117830 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine